Bart Neyns
机构: Diensthoofd, Medische Oncologie, Universitair Ziekenhuis Brussel
每年引用次数
引用次数
引用: 33,394
H-指数: 72
I10-指数 : 206
出版物: 545
Frequent deletion of chromosome 19 and a rare rearrangement of 19p13.3 involving the insulin receptor gene in human ovarian cancer.
Neyns B , Amfo K , Bourgain C , Lissens W
Oncogene 11 ( 2) 351 -358
19
1995
The role of chemotherapy in the treatment of low-grade glioma. A review of the literature.
Keyaerts M , Neyns B , Sadones J , Michotte A
Acta Neurologica Belgica 105 ( 3) 137 -143
6
2005
Intratumoral gene therapy for non-small cell lung cancer: current status and future directions.
Noppen M , Neyns B
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo 59 ( 4) 287 -295
8
2003
Het gekartelde ("serrated") adenoom en de hyperplastische polypose
Neyns B , Delvaux G , Sermon F , Marichal-Pipeleers M
Tijdschrift Voor Geneeskunde 60 ( 5) 346 -353
2004
Het hormoonresistente prostaatadenocarcinoom: heden en toekomst
Neyns B , Keuppens F , Michielsen D , Thielemans K
Tijdschrift Voor Geneeskunde 60 ( 4) 276 -283
2004
Insufficient TGF-beta 1 production inactivates the autocrine growth suppressive circuit in human ovarian cancer cell lines.
Neyns B , Zeinoun Z , Geerts A , De Greve J
Anticancer Research 19 413 -420
12
1999
Small bowel metastases from melanoma: does videocapsule provide additional information after FDG positron emission tomography?
C. Reenaers , Bart Neyns , Fazia Mana , Daniel Urbain
Acta Gastro-enterologica Belgica 75 ( 2) 219 -221
2012
2-(18F)-Fluoromethyl-L-phenylalanine PET in progressive glioma
Tony Lahoutte , Bart Neyns , Ken Kersemans , Vicky Caveliers
The Journal of Nuclear Medicine 49
2008
Bevacizumab for recurrent glioblastoma, early observations on patient outcome in the belgian medical need program
Bart Neyns , Eric Joosens , Christine Gennigens , Johnny Duerinck
Neuro-oncology 14 ( 3) 51 -51
1
2012
The role of cytotoxic drugs in the treatment of central nervous system gliomas.
Bart Neyns , Joy Van de Cauter , Miguel D'haeseleer , Alex Michotte
Acta Neurologica Belgica 110 ( 1) 1 -14
13
2010
Cetuximab with Hepatic Arterial Infusion of Chemotherapy for the Treatment of Colorectal Cancer Liver Metastases
Yves Van Nieuwenhove , Bart Neyns , Georges Delvaux , Frederik Vandenbroucke
Anticancer Research 28 2459 -2467
12
2008
Sarcoidosis in a patient with metastatic melanoma sequentially treated with anti-CTLA-4 monoclonal antibody and selective BRAF inhibitor.
Bart Neyns , Amélie Clémentine Seghers , Frederik Vandenbroucke , Stephanie Du Four
Anticancer Research 32 ( 4) 1355 -1359
61
2012
Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomide
Bart Neyns , Roger Stupp , Anne Hoorens
Acta Neurologica Belgica 108 ( 4) 131 -134
10
2008
Long-term Disease-free Survival Following Dendritic Cell Therapy and Resection of Small Bowel Melanoma Metastases – A Case Report
Bart Neyns , Georges Delvaux , Kristel De Vogelaere , Sofie Wilgenhof
Anticancer Research 31 ( 10) 3579 -3583
1
2011
Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases
Yves Van Nieuwenhove , Bart Neyns , Joanna Vermeij , Georges Delvaux
Anticancer Research 26 611 -619
24
2006
Correlation between IDH1 gene mutation status and survival of patients treated for recurrent glioma.
Bart Neyns , Jan Sadones , Erik Teugels , Shasha Lv
Anticancer Research 31 ( 12) 4457 -4463
29
2011
Sarcoidosis in a metastatic melanoma patient treated with the CTLA-4 inhibitory monoclonal antibody ipilimumab
Bart Neyns , Shane Wendy Hanon , Frederik Vandenbroucke , Sofie Wilgenhof
Belgian Journal of Medical Oncology 6 58 -62
2012
Biomarker Analysis in a Phase II Study of Sunitinib in Patients with Advanced Melanoma.
Bart Neyns , Jacques De Grève , Sylvia De Brakeleer , Sylvie Rottey
Anticancer Research 35 ( 12) 6893 -6899
11
2015
Treatment effect of panitumumab in subsets by epidermal growth factor receptor (EGFR) status from a phase 3 randomized controlled trial
Eric Van Cutsem , Bart Neyns , Joan Maurel , Jean-Luc Van Laethem
Annals of Oncology 17 249 -249
3
2006
Complete metabolic tumor response, assessed by 18FDG-PET, after induction chemotherapy in patients (pts) with locally advanced non small cell lung carcinoma (NSCLC) predicts longer time to progression (TTP) and survival (S)
Johan de Mey , Nick Baelde , Marc Meysman , Denis Schallier
The Journal of Nuclear Medicine 47
1
2006